Arunity Ellipta (Fluticasone Furoate) is to be taken:

Arunity Ellipta (Fluticasone Furoate) is classified as a long-acting inhaled corticosteroid specifically designed for the management of asthma and chronic obstructive pulmonary disease (COPD). The correct administration frequency is once daily, which is a key feature of this medication.

Taking it once a day allows for stable control of airway inflammation and reduces the frequency of asthma exacerbations. This daily regimen is beneficial as it simplifies the treatment process for patients and enhances adherence to the prescribed therapy, ensuring more consistent management of their condition.

The other options suggest more frequent dosing or irregular use, which does not align with the recommended use for Fluticasone Furoate. Using it twice daily or as needed can lead to fluctuations in medication levels in the body, potentially diminishing the effectiveness of the treatment and increasing the risk of complications. Therefore, once daily administration is optimal for maintaining effective control over respiratory conditions.